Skip to main content
Erschienen in: Pediatric Nephrology 2/2009

01.02.2009 | Letter to the Editors

Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab

verfasst von: Ajay P. Sharma, Guido Filler

Erschienen in: Pediatric Nephrology | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Excerpt

Sirs, …
Literatur
1.
Zurück zum Zitat Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F (2008) Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 23:1269–1279CrossRef Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F (2008) Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 23:1269–1279CrossRef
2.
Zurück zum Zitat Suri M, Tran K, Sharma AP, Filler G, Grimmer J (2008) Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab. Int Urol Nephrol 40:807–810CrossRef Suri M, Tran K, Sharma AP, Filler G, Grimmer J (2008) Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab. Int Urol Nephrol 40:807–810CrossRef
3.
Zurück zum Zitat Nakayama M, Kamei K, Nozu K, Matsuoka K, Nakagawa A, Sako M, Iijima K (2008) Rituximab for refractory focal segmental glomerulosclerosis. Pediatr Nephrol 23:481–485CrossRef Nakayama M, Kamei K, Nozu K, Matsuoka K, Nakagawa A, Sako M, Iijima K (2008) Rituximab for refractory focal segmental glomerulosclerosis. Pediatr Nephrol 23:481–485CrossRef
4.
Zurück zum Zitat Filler G, Hansen M, LeBlanc C, Lepage N, Franke D, Mai I, Feber J (2003) Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children. Pediatr Nephrol 18:445–449CrossRef Filler G, Hansen M, LeBlanc C, Lepage N, Franke D, Mai I, Feber J (2003) Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children. Pediatr Nephrol 18:445–449CrossRef
5.
Zurück zum Zitat Allison AC, Eugui EM (1996) Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant 10:77–84PubMed Allison AC, Eugui EM (1996) Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant 10:77–84PubMed
Metadaten
Titel
Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab
verfasst von
Ajay P. Sharma
Guido Filler
Publikationsdatum
01.02.2009
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 2/2009
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-008-1030-8

Weitere Artikel der Ausgabe 2/2009

Pediatric Nephrology 2/2009 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.